Clinical features of HNC patients from the clinical trial UPCI #08-013
| Patients, n (%) | 6 (100) |
| Gender, n (%) | |
| Male | 4 (66.6) |
| Female | 2 (33.3) |
| Age, years; median (range) | 57.5 (47–74) |
| T stage, n (%) | |
| T1 | 1 (16.6) |
| T2 | 1 (16.6) |
| T3 | 1 (16.6) |
| T4 | 3 (50) |
| N stage, n (%) | |
| N0 | 2 (33.3) |
| N1 | 2 (33.3) |
| N2 | 2 (33.3) |
| Tumor site, n (%) | |
| Oral cavity | 2 (33.3) |
| Tonsil | 2 (33.3) |
| Larynx | 2 (33.3) |
| HPV status, n (%) | |
| Positive | 2 (33.5) |
| Not evaluated | 4 (66.5) |
| Response status, n (%) | |
| Responder | 3 (50) |
| Partial responder | 1 (16.6) |
| Nonresponder | 1 (16.6) |
| Not available | 1 (16.6) |